Translational Research Institute

What happens if someone dies in space?

Retrieved on: 
Monday, July 31, 2023
Translational Research Institute, Travel, Solar System, Kid, Soyuz 11, Spacecraft, International Space Station, Burial, Asphyxia, Apollo, Cremation, Humidity, NASA, Blood, Fluid mechanics, No, Death, Bacteria, Toy, Communications satellite, Transport, Gypsum, Oil, Food preservation, Mars, Moon

What happens if someone dies in space?

Key Points: 
  • What happens if someone dies in space?
  • Given how complicated human spaceflight is, it’s actually remarkable how few people have lost their lives so far.
  • But NASA plans to send a crew to the Moon in 2025 and astronauts to Mars in the next decade.
  • It brings to mind a gloomy but necessary question to ask: If someone dies in space – what happens to the body?

WARF board welcomes three new trustees

Retrieved on: 
Monday, July 10, 2023
Data management, Translational Research Institute, Laboratory, University, UW, Engineer Research and Development Center, Collins, Wisconsin Alumni Research Foundation, Biomedical Research, United States Air Force Scientific Advisory Board, American Nurses Association, Research, Economics, Genentech, Medtronic, Retirement, NASA, Investment, Chairperson, Biology, DNAnexus, Richard C. Perry, Therapy, Jan Vansina, American Family Insurance, WARF, University of Wisconsin–Madison, Management, Nursing, Trustee

MADISON, Wis., July 10, 2023 /PRNewswire/ -- Asha Collins, Paul Leff and Thomas Tefft, three leading executives in the fields of biomedical research, investments and corporate medical device innovation, have joined the board of the Wisconsin Alumni Research Foundation (WARF).

Key Points: 
  • Asha Collins brings 18 years of biomedical research experience to the WARF Board of Trustees.
  • "I'm honored to join the WARF board and look forward to assisting the organization to further its worthy mission," says Leff.
  • "Asha, Paul and Tom bring tremendous experience to the WARF Board of Trustees," says Erik Iverson, WARF's CEO.
  • "All three are graduates of UW-Madison, have exemplary careers in their fields, and share the same dedication to the university as the other WARF trustees.

Review of the NLRP3 Inflammasome Inhibitor RRx-001 Published in the Prestigious Scientific Journal, Drugs

Retrieved on: 
Tuesday, March 21, 2023
Neuroprotection, Carcinoma, Translational Research Institute, TRI, Shake it Up Australia Foundation, Acute radiation syndrome, Myocardial infarction, ARS, Inflammasome, Disease, The Michael J. Fox Foundation, Cancer, NLRP3, ALS, Head, Research, Inflammation, Multiple sclerosis, CNS, DSM-IV codes, Associate, Translational Research Institute (Australia), Acute kidney injury, Parkinson's disease, MJFF, Patient, CMR, Pulmonary hypertension, University of Queensland, Alzheimer's disease, Malaria, Pharmaceutical industry

The article is entitled, A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation.

Key Points: 
  • The article is entitled, A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation.
  • Dr. Gordon is an
    internationally recognized expert on inflammasome signaling in neurodegenerative diseases.
  • RRx-001 has been evaluated in multiple independent studies for conditions where immune and inflammasome activation contribute to disease pathology.
  • These include cancer, myocardial infarction, pulmonary hypertension, acute kidney injury, acute radiation syndrome (ARS), malaria, multiple sclerosis, Parkinson's disease, and Alzheimer's disease.

Garmin smartwatches reach new heights with Polaris Dawn space mission

Retrieved on: 
Tuesday, February 7, 2023
Commerce, Kennedy Space Center, Population health, Dawn, Sleep, Human, Translational Research Institute, Falcon 9, Spaceflight, SpaceX, Baylor University, API, Biomedical Research, Polaris, Database, Research, Health, Privacy, NASA, Heart rate, SpaceX launch vehicles, Baylor College of Medicine, Garmin, Polaris Dawn, Communications satellite, Satellite navigation device

OLATHE, Kan., Feb. 7, 2023 /PRNewswire/ -- Garmin smartwatches will play an important role in an upcoming Polaris Dawn human spaceflight, with highly accurate health data gleaned from fēnix® 7 adventure watches providing 24/7 insights into the impact of space travel on the human body. During the up to five-day mission launched from the SpaceX Falcon 9 rocket at NASA's Kennedy Space Center in Florida, researchers will continuously monitor and collect crew members' biometrics such as heart rate, pulse oximetry, and sleep patterns—all on a single battery charge.

Key Points: 
  • "Garmin is honored to be a part of this exciting research effort that will advance the understanding of how the human body adapts to the rigors of space flight," said Dan Bartel, Garmin vice president of global sales.
  • The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine is supporting health and biomedical research aboard the historic Polaris Dawn mission, which will attempt to reach the highest Earth orbit ever flown with humans and complete the first-ever commercial spacewalk.
  • The Polaris Dawn crew and the TRISH team chose Garmin smartwatches for the mission because of their long battery life, rugged durability and extensive suite of all-day health monitoring features.
  • SpaceX's Falcon 9 rocket will launch the Polaris Dawn crew aboard a Dragon spacecraft from NASA's Kennedy Space Center in Cape Canaveral, FL later in 2023.

BioIntelliSense named CES 2023 Innovation Award Honoree for its BioButton® continuous monitoring and clinical intelligence solutions for in-hospital to home

Retrieved on: 
Thursday, January 5, 2023
Translational Research Institute, Partnership, Consumer Technology Association, MD, CES, Transport, Organization, Patient, CTA, Health, Gait analysis, FDA, Skin temperature, Maternal health, Engineering, SpaceX, Medical device

DENVER, Jan. 05, 2023 (GLOBE NEWSWIRE) -- BioIntelliSense , a continuous health monitoring and clinical intelligence company, has been named a CES® 2023 Innovation Awards Honoree for its BioButton® medical-grade wearable and advanced data analytics that make continuous vital sign monitoring simple and cost-effective from in-hospital to home.

Key Points: 
  • DENVER, Jan. 05, 2023 (GLOBE NEWSWIRE) -- BioIntelliSense , a continuous health monitoring and clinical intelligence company, has been named a CES® 2023 Innovation Awards Honoree for its BioButton® medical-grade wearable and advanced data analytics that make continuous vital sign monitoring simple and cost-effective from in-hospital to home.
  • The CES Innovation Awards program, owned and produced by the Consumer Technology Association® (CTA), is an annual competition honoring outstanding design and engineering in 28 consumer technology product categories.
  • “We’re proud to be honored once again with the prestigious CES Innovation Award,” said James Mault, MD, founder and CEO of BioIntelliSense.
  • Owned and produced by CTA, CES 2023 will take place in Las Vegas on January 5-8, 2023.

Amedisys Completes Home Health Joint Venture with the University of Arkansas for Medical Sciences

Retrieved on: 
Tuesday, December 13, 2022
Baptist Health, Contessa, Translational Research Institute, Rehabilitation, Student, Palliative care, ROCK, Eating, Ageing, The Neurosciences Institute, Trauma, MBA, Investment, Arkansas Children's Hospital, Information, Modern Healthcare, Veterans Health Administration, Terrorism, Hospital, Home, Star, UAMS, QPC, Digital health, Level 1, Health, Winthrop, Lexington VA Medical Center, University of Arkansas for Medical Sciences, University, Patient, Hospice, Physician, Failure, Northwestern Health Sciences University, Government, Climate change, Anatomical pathology, The Last Best Place, Conditional sentence, Health care, Public health, Partnership, Medicine, Health insurance, Nursing, Pharmacy, Medicare, Central Arkansas, Amedisys

and NASHVILLE, Tenn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its joint venture with the University of Arkansas for Medical Sciences (UAMS) to provide home health services in Searcy and Little Rock.

Key Points: 
  • and NASHVILLE, Tenn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its joint venture with the University of Arkansas for Medical Sciences (UAMS) to provide home health services in Searcy and Little Rock.
  • This joint venture is part of the partnership between UAMS, Amedisys and Contessa, an Amedisys company, to offer patients a full spectrum of medical care in the comfort and convenience of their own homes through UAMS Health Comprehensive Care at Home.
  • Home health services will operate as UAMS Health Home Health across 12 counties in Central Arkansas.
  • Amedisys is the second largest provider of home health care and the third largest provider of hospice care in the United States.

Australian Scientists Honoured with the Grand Hamdan Award

Retrieved on: 
Thursday, November 24, 2022
Future, Human papillomavirus infection, Cervical cancer, Museum, Late, Award, Sheikh Rashid bin Saeed Crossing, University, Medical research, Multimedia, Faculty of Medicine, University of Malaya, Museum of the Future (Dubai), HPV, University of Queensland, Faculty, Immunology, Translational Research Institute, Hamdan, Research, Infection, TRI, Pharmaceutical industry, Medicine

DUBAI, UAE, Nov. 24, 2022 /PRNewswire/ -- The Award ceremony of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, hosted in Dubai, took place on 23rd of November the Museum of the Future.

Key Points: 
  • DUBAI, UAE, Nov. 24, 2022 /PRNewswire/ -- The Award ceremony of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, hosted in Dubai, took place on 23rd of November the Museum of the Future.
  • The Award celebrated its 12th term (2021-2022) and 22nd year, in the presence of Sheikh Rashid bin Hamdan bin Rashid Al Maktoum, who personally awarded the 14 winners.
  • Prof. Ian Hector Frazer and Late Dr. Jian Zhou were awarded with the prestigious Grand Hamdan Award in the field of Infectious Diseases.
  • Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences is a non-profit organization that honors researchers worldwide who carry out distinguished medical research to serve humanity.

BioIntelliSense Joins Polaris Dawn Mission to Advance Understanding of Human Health in Space

Retrieved on: 
Monday, November 14, 2022
Wearables, Mobile Technology, Other Transport, Biometrics, Other Health, Air, Transport, Telecommunications, Medical Devices, Internet, Hardware, Data Management, Consumer Electronics, Practice Management, Technology, Mobile, Wireless, Biotechnology, Health, Apps, Applications, Health Technology, Orbit, MIT, California Institute of Technology, NASA, Exploration, Partnership, News, SpaceX, Vital signs, Translational Research Institute, Data, Astronaut, RPM, Health, MD, Data as a service, Movement, Pharmaceutical industry, Medical device

BioIntelliSense, Inc ., a continuous health monitoring and clinical intelligence company, today announced its partnership with the Translational Research Institute for Space Health (TRISH) to further understanding of human health in space.

Key Points: 
  • BioIntelliSense, Inc ., a continuous health monitoring and clinical intelligence company, today announced its partnership with the Translational Research Institute for Space Health (TRISH) to further understanding of human health in space.
  • The BioButton medical grade wearable device will be used for commercial spaceflight research programs and notably during the upcoming five-day Polaris Dawn mission.
  • Medical and scientific research on human health in space promotes the advancement of translational technologies by adapting known technology for space applications, and by using space-based insights to improve healthcare at home.
  • TRISH is proud to partner with innovative healthcare technology leaders like BioIntelliSense as we further our understanding of human health in space, said James Hury, TRISH Chief Innovation Officer and Deputy Director.

Canary Medical Announces Appointment of Lisa Suennen as President, Digital and Data Solutions

Retrieved on: 
Tuesday, October 25, 2022
Jean-Auguste-Dominique Ingres, Sale, Informatics, Technology, Medical Technology Group, Growth, Director, Founding, Berkeley, General partnership, LLC, NASA, IPO, Patient, Business, Senior, Data management, University, Partner (business rank), X/Open, Information technology, Manatt, Phelps & Phillips, Ecosystem, Faculty, Translational Research Institute, GE Ventures, GLOBE, Political science, Advisory board, Aspen, Digital, The Advisory Board Company, Communication, Health, Compliance, Magellan Health, Pharmaceutical industry, Management

VANCOUVER, British Columbia and CARLSBAD, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Canary Medical, a medical data company focused on the development and commercialization of its patented implantable sensor technology and data management ecosystem, today announced the appointment of Lisa Suennen as President, Digital and Data Solutions.

Key Points: 
  • VANCOUVER, British Columbia and CARLSBAD, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Canary Medical, a medical data company focused on the development and commercialization of its patented implantable sensor technology and data management ecosystem, today announced the appointment of Lisa Suennen as President, Digital and Data Solutions.
  • Ms. Suennen previously served as the Group Practice Lead for Manatt Phelps and Philips Digital and Technology Group and Managing Partner for the Manatt Venture Fund.
  • Her deep understanding of the application of digital health and information technology in the health services, medical device and pharmaceutical industries will help guide the growth and commercialization of Canary Medicals digital health and data-focused product offerings.
  • Canary Medical is led by a team of experienced entrepreneurs, researchers and data scientists globally regarded for their expertise in medical device design, development and data informatics.

Polaris Dawn Selects 38 Science and Research Experiments to Advance Human Health and Space Exploration

Retrieved on: 
Monday, October 24, 2022
Pressure, University of Colorado Boulder, Astronaut, Risk, University of Colorado, Growth, Population, Science, University of Texas at Austin, NASA, Medical school, Weill Cornell Medicine, Airway management, Polaris, Field line, Research, Medical University of South Carolina, Kennedy Space Center Launch Complex 39A, Institute of Environmental Science and Research, Brain mapping, Applied Physics Laboratory, MRI, SANS, Eye, Knowledge, University, Pacific Northwest National Laboratory, Health, SpaceX, Safety, University Hospital (Augusta, Georgia), Translational Research Institute, Gravitropism, Cardiopulmonary resuscitation, Brain, CPR, Kennedy Space Center, Travel, Baylor College of Medicine, Moon, Program, Transport, Medical imaging, Pharmaceutical industry, Mars, Dragon

The selected projects are designed to advance both human health on Earth and on future long-duration spaceflights.

Key Points: 
  • The selected projects are designed to advance both human health on Earth and on future long-duration spaceflights.
  • "The mission profile of Polaris Dawn affords us some great opportunities to expand our collective knowledge about the human body in space and associated applicability here on Earth.
  • The Polaris Dawn team along with the exceptional science and research team at SpaceX cast a wide net to find the best experiments to fly with us.
  • For a full list and description of the selected science & research experiments and associated institutions, visit Polaris Dawn's Science and Research site .